VisionSys AI Inc is a holding company primarily engaged in the development of brain-computer interface (BCI) technologies and related businesses. The Company's main business is developing, procuring, selling, and distributing BCI-enabled or BCI-adjacent products and solutions, and to provide related technical services. The BCI technologies are used in medical and healthcare-related applications, including functional rehabilitation, communication support, neurological disease-related monitoring and intervention, sensory assistance, and general wellness management. The Company mainly operates its businesses in the domestic market.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
13/08/26	$3.700	+0.82%	24,987
12/08/26	$3.670	-3.17%	94,192
11/08/26	$3.790	+12.80%	224,551
10/08/26	$3.360	-11.58%	742,098
07/08/26	$3.800	+24.59%	3,171,153

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

Market Closed - Nasdaq 23:00:00 13/08/2026 +03			5-day change	1st Jan Change
3.700 ^USD	+0.82%		+21.31%	-84.77%

07-31	Certain Class B Ordinary Shares of VisionSys AI Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2026.	CI
07-31	Certain Class A Ordinary Shares of VisionSys AI Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2026.	CI

Market Cap	15.51M 2.3M 1.99M 1.87M 1.7M 3.21M 219M 3.26M 22M 8.59M 110M 8.63M 8.45M 366M	P/E 2024	-0.09x	P/E 2025	0.01x
Enterprise Value	-37.94M -5.62M -4.88M -4.57M -4.17M -7.84M -537M -7.97M -53.81M -21.01M -269M -21.12M -20.66M -896M	EV / Sales 2024	0.22x	EV / Sales 2025	-34.3x
Free-Float	13.24%	Yield 2024 *	-	Yield 2025	-

07-31	Certain Class B Ordinary Shares of VisionSys AI Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2026.	CI
07-31	Certain Class A Ordinary Shares of VisionSys AI Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2026.	CI
07-31	Certain American Depositary Shares of VisionSys AI Inc. are subject to a Lock-Up Agreement Ending on 31-JUL-2026.	CI
07-10	VisionSys AI Inc. announced that it expects to receive $91.75 million in funding	CI
06-02	Top Premarket Gainers	MT
05-11	VisionSys AI Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-05	Visionsys Ai Inc - to change ADS ratio from 1:250 to 1:2500 effective May 26, 2026	RE
05-05	Visionsys Ai Inc - to change ADS ratio from 1:250 to 1:2500 class A ordinary shares	RE
04-28	Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	MT
04-27	VisionSys AI announces proposed $90 million strategic investment at $1.50/share	RE
04-27	VisionSys AI Inc. announced that it expects to receive $90 million in funding	CI
03-27	Wall Street Set to Open Lower in Friday Trading; Investors Not Assuaged by US Deadline Extension for Iran to Open Strait of Hormuz	MT
03-14	Certain American Depositary Shares of VisionSys AI Inc. are subject to a Lock-Up Agreement Ending on 14-MAR-2026.	CI

24/10/25	VisionSys AI Inc Announces Board Changes	CI
14/06/23	EF Hutton Adjusts Price Target on Tarena International to $8 From $11, Keeps Buy Rating	MT
29/03/23	EF Hutton Adjusts Price Target on Tarena International to $11 From $12, Maintains Buy Rating	MT
27/02/23	EF Hutton Initiates Coverage on Tarena International With Buy Rating, $12 Price Target	MT

VisionSys AI Inc. Stock

Stocks

VSA

US8761084081

Biotechnology & Medical Research

Valuation: VisionSys AI Inc.

Chart: VisionSys AI Inc.

Latest news : VisionSys AI Inc.

Analysts' recommendations: VisionSys AI Inc.

Press Releases: VisionSys AI Inc.

Quotes and Performance

Course Extremes

Managers and Directors: VisionSys AI Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates

05-20	VisionSys AI Inc Announces ADS Ratio Change with Marketplace Effective Date on May 26, 2026	GL
05-05	VisionSys AI Inc Announces Planned ADS Ratio Change	GL
05-05	VisionSys AI Inc Announces Planned ADS Ratio Change	AQ
04-27	VisionSys AI Inc. Announces Proposed $90 Million Strategic Investment at $1.50 Per Share	GL
03-27	VisionSys AI Inc. Announces Pricing of $3 Million Registered Direct Offering	GL

1 day	+0.82%
1 week	+21.31%
Current month	+23.75%
1 month	+15.62%
3 months	-16.23%
6 months	-78.74%
Current year	-84.77%

1 week	3.2	4
1 month	2.76	7.97
Current year	2.76	33.65
1 year	2.76	2,120.35
3 years	2.76	2,120.35
5 years	2.76	4,500
10 years	2.76	54,250

Manager	Title	Age	Since
Tian Long Wang CEO	Chief Executive Officer	40	05/12/2025
Diyu Jiang DFI	Director of Finance/CFO	-	05/12/2025
Ying Sun CEO	Chief Executive Officer	50	08/04/2021

Director	Title	Age	Since
Jian Guang Li BRD	Director/Board Member	61	01/04/2014
Ming Jie Sun BRD	Director/Board Member	62	01/12/2022
WU Xiaoxia BRD	Director/Board Member	-	05/12/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VISIONSYS AI INC.	+0.82%	+21.31%	-99.56%	-99.70%	2.3M
LONZA GROUP AG	-2.11%	-1.68%	+1.99%	+13.84%	49.24B
REVOLUTION MEDICINES, INC.	-1.59%	+2.12%	+460.02%	+573.56%	43.3B
BEONE MEDICINES AG	-0.85%	+7.95%	+15.77%	+80.09%	40.48B
IQVIA HOLDINGS INC.	-0.08%	+3.91%	+26.96%	+9.86%	39.75B
CELLTRION, INC.	0.00%	+3.59%	+20.51%	+48.00%	32.67B
ASCENDIS PHARMA A/S	-3.61%	-1.45%	-	-	16.23B
MEDPACE HOLDINGS, INC.	-2.52%	-0.52%	+24.35%	+118.05%	16.24B
EUROFINS SCIENTIFIC SE	+1.00%	+1.46%	+4.89%	+22.82%	14.04B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.09%	+5.94%	+81.46%	+31.15%	13.43B
Average	-1.00%	+4.20%	+59.60%	+88.63%	26.54B
Weighted average by Cap.	-1.17%	+2.71%	+96.14%	+133.95%

	2024	2025
Net sales	1.17B 174M 150M 141M 129M 242M 16.57B 246M 1.66B 648M 8.29B 652M 638M 27.67B	1.04M 154K 134K 125K 114K 215K 14.7M 218K 1.47M 575K 7.36M 578K 566K 24.55M
Net income	-587M -86.97M -75.38M -70.67M -64.43M -121M -8.3B -123M -832M -325M -4.15B -326M -319M -13.86B	1.72B 255M 221M 207M 189M 355M 24.32B 361M 2.44B 952M 12.18B 957M 936M 40.62B
Net Debt	208M 30.83M 26.72M 25.05M 22.84M 42.97M 2.94B 43.66M 295M 115M 1.47B 116M 113M 4.91B	-53.44M -7.92M -6.87M -6.44M -5.87M -11.05M -756M -11.22M -75.82M -29.6M -379M -29.75M -29.11M -1.26B